Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Diversity of innate immune cell subsets across spatial and temporal scales in an EAE mouse model.

Caravagna C, Jaouën A, Desplat-Jégo S, Fenrich KK, Bergot E, Luche H, Grenot P, Rougon G, Malissen M, Debarbieux F.

Sci Rep. 2018 Mar 23;8(1):5146. doi: 10.1038/s41598-018-22872-y.

2.

Phosphoinositides regulate the TCR/CD3 complex membrane dynamics and activation.

Chouaki-Benmansour N, Ruminski K, Sartre AM, Phelipot MC, Salles A, Bergot E, Wu A, Chicanne G, Fallet M, Brustlein S, Billaudeau C, Formisano A, Mailfert S, Payrastre B, Marguet D, Brasselet S, Hamon Y, He HT.

Sci Rep. 2018 Mar 21;8(1):4966. doi: 10.1038/s41598-018-23109-8.

3.

Diagnostic value of quantitative assessment of cardiac 18F-fluoro-2-deoxyglucose uptake in suspected cardiac sarcoidosis.

Lebasnier A, Legallois D, Bienvenu B, Bergot E, Desmonts C, Zalcman G, Agostini D, Manrique A.

Ann Nucl Med. 2018 Jun;32(5):319-327. doi: 10.1007/s12149-018-1250-3. Epub 2018 Mar 20.

PMID:
29560563
4.

[About atypic tissular mass].

Guimas M, Le Palud P, Bergot E.

Rev Pneumol Clin. 2018 Apr;74(2):115-117. doi: 10.1016/j.pneumo.2018.01.001. French. No abstract available.

PMID:
29402487
5.

Heart rate and risk of death among patients with Pulmonary Hypertension: A 12-lead ECG analysis.

Bouchery-Bardet H, Creveuil C, Bauer F, Beygui F, Champ-Rigot L, Saloux E, Labombarda F, Roule V, Sabatier R, Legallois D, Zalcman G, Bergot E, Milliez P.

Respir Med. 2017 Nov;132:42-49. doi: 10.1016/j.rmed.2017.09.008. Epub 2017 Sep 22.

PMID:
29229104
6.

Management and long-term outcomes of sarcoidosis-associated pulmonary hypertension.

Boucly A, Cottin V, Nunes H, Jaïs X, Tazi A, Prévôt G, Reynaud-Gaubert M, Dromer C, Viacroze C, Horeau-Langlard D, Pison C, Bergot E, Traclet J, Weatherald J, Simonneau G, Valeyre D, Montani D, Humbert M, Sitbon O, Savale L.

Eur Respir J. 2017 Oct 19;50(4). pii: 1700465. doi: 10.1183/13993003.00465-2017. Print 2017 Oct.

PMID:
29051269
7.

[French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis. 2017 update. Full-length update].

Cottin V, Crestani B, Cadranel J, Cordier JF, Marchand-Adam S, Prévot G, Wallaert B, Bergot E, Camus P, Dalphin JC, Dromer C, Gomez E, Israel-Biet D, Jouneau S, Kessler R, Marquette CH, Reynaud-Gaubert M, Aguilaniu B, Bonnet D, Carré P, Danel C, Faivre JB, Ferretti G, Just N, Lebargy F, Philippe B, Terrioux P, Thivolet-Béjui F, Trumbic B, Valeyre D.

Rev Mal Respir. 2017 Sep 21. pii: S0761-8425(17)30209-7. doi: 10.1016/j.rmr.2017.07.018. [Epub ahead of print] French. No abstract available.

8.

French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis - 2017 update. Full-length version.

Cottin V, Crestani B, Cadranel J, Cordier JF, Marchand-Adam S, Prévot G, Wallaert B, Bergot E, Camus P, Dalphin JC, Dromer C, Gomez E, Israel-Biet D, Jouneau S, Kessler R, Marquette CH, Reynaud-Gaubert M, Aguilaniu B, Bonnet D, Carré P, Danel C, Faivre JB, Ferretti G, Just N, Lebargy F, Philippe B, Terrioux P, Thivolet-Béjui F, Trumbic B, Valeyre D.

Rev Mal Respir. 2017 Oct;34(8):900-968. doi: 10.1016/j.rmr.2017.07.017. Epub 2017 Sep 20. No abstract available.

PMID:
28939155
9.

French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis - 2017 update. Short-length version.

Cottin V, Crestani B, Cadranel J, Cordier JF, Marchand-Adam S, Prévot G, Wallaert B, Bergot E, Camus P, Dalphin JC, Dromer C, Gomez E, Israel-Biet D, Jouneau S, Kessler R, Marquette CH, Reynaud-Gaubert M, Aguilaniu B, Bonnet D, Carré P, Danel C, Faivre JB, Ferretti G, Just N, Lebargy F, Philippe B, Terrioux P, Thivolet-Béjui F, Trumbic B, Valeyre D.

Rev Mal Respir. 2017 Oct;34(8):852-899. doi: 10.1016/j.rmr.2017.07.019. Epub 2017 Sep 20. No abstract available.

PMID:
28939154
10.

[French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis: 2017 update. Short-length version].

Cottin V, Crestani B, Cadranel J, Cordier JF, Marchand-Adam S, Prévot G, Wallaert B, Bergot E, Camus P, Dalphin JC, Dromer C, Gomez E, Israel-Biet D, Jouneau S, Kessler R, Marquette CH, Reynaud-Gaubert M, Aguilaniu B, Bonnet D, Carré P, Danel C, Faivre JB, Ferretti G, Just N, Lebargy F, Philippe B, Terrioux P, Thivolet-Béjui F, Trumbic B, Valeyre D.

Rev Mal Respir. 2017 Sep 18. pii: S0761-8425(17)30211-5. doi: 10.1016/j.rmr.2017.07.020. [Epub ahead of print] French. No abstract available.

PMID:
28935497
11.

[French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis: 2017 update. Summary].

Cottin V, Crestani B, Cadranel J, Cordier JF, Marchand-Adam S, Prévot G, Wallaert B, Bergot E, Camus P, Dalphin JC, Dromer C, Gomez E, Israel-Biet D, Jouneau S, Kessler R, Marquette CH, Reynaud-Gaubert M, Aguilaniu B, Bonnet D, Carré P, Danel C, Faivre JB, Ferretti G, Just N, Lebargy F, Philippe B, Terrioux P, Thivolet-Béjui F, Trumbic B, Valeyre D.

Rev Mal Respir. 2017 Sep 19. pii: S0761-8425(17)30212-7. doi: 10.1016/j.rmr.2017.07.021. [Epub ahead of print] French. No abstract available.

PMID:
28935496
12.

French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis: 2017 update. Summary.

Cottin V, Crestani B, Cadranel J, Cordier JF, Marchand-Adam S, Prévot G, Wallaert B, Bergot E, Camus P, Dalphin JC, Dromer C, Gomez E, Israel-Biet D, Jouneau S, Kessler R, Marquette CH, Reynaud-Gaubert M, Aguilaniu B, Bonnet D, Carré P, Danel C, Faivre JB, Ferretti G, Just N, Lebargy F, Philippe B, Terrioux P, Thivolet-Béjui F, Trumbic B, Valeyre D.

Rev Mal Respir. 2017 Oct;34(8):834-851. doi: 10.1016/j.rmr.2017.07.022. Epub 2017 Sep 19. No abstract available.

PMID:
28935495
13.

Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension.

Boucly A, Weatherald J, Savale L, Jaïs X, Cottin V, Prevot G, Picard F, de Groote P, Jevnikar M, Bergot E, Chaouat A, Chabanne C, Bourdin A, Parent F, Montani D, Simonneau G, Humbert M, Sitbon O.

Eur Respir J. 2017 Aug 3;50(2). pii: 1700889. doi: 10.1183/13993003.00889-2017. Print 2017 Aug.

PMID:
28775050
14.

Predicting susceptibility to tuberculosis based on gene expression profiling in dendritic cells.

Blischak JD, Tailleux L, Myrthil M, Charlois C, Bergot E, Dinh A, Morizot G, Chény O, Platen CV, Herrmann JL, Brosch R, Barreiro LB, Gilad Y.

Sci Rep. 2017 Jul 18;7(1):5702. doi: 10.1038/s41598-017-05878-w.

15.

MSH2/BRCA1 expression as a DNA-repair signature predicting survival in early-stage lung cancer patients from the IFCT-0002 Phase 3 Trial.

Levallet G, Dubois F, Fouret P, Antoine M, Brosseau S, Bergot E, Beau-Faller M, Gounant V, Brambilla E, Debieuvre D, Molinier O, Galateau-Sallé F, Mazieres J, Quoix E, Pujol JL, Moro-Sibilot D, Langlais A, Morin F, Westeel V, Zalcman G.

Oncotarget. 2017 Jan 17;8(3):4313-4329. doi: 10.18632/oncotarget.14025.

16.

The scaffolding function of the RLTPR protein explains its essential role for CD28 co-stimulation in mouse and human T cells.

Roncagalli R, Cucchetti M, Jarmuzynski N, Grégoire C, Bergot E, Audebert S, Baudelet E, Menoita MG, Joachim A, Durand S, Suchanek M, Fiore F, Zhang L, Liang Y, Camoin L, Malissen M, Malissen B.

J Exp Med. 2016 Oct 17;213(11):2437-2457. Epub 2016 Sep 19.

17.

Adherence to guidelines in idiopathic pulmonary fibrosis: a follow-up national survey.

Cottin V, Bergot E, Bourdin A, Cadranel J, Camus P, Crestani B, Dalphin JC, Delaval P, Dromer C, Israel-Biet D, Kessler R, Marchand-Adam S, Marquette CH, Prévot G, Reynaud-Gaubert M, Valeyre D, Wallaert B, Bouquillon B, Cordier JF.

ERJ Open Res. 2015 Nov 16;1(2). pii: 00032-2015. eCollection 2015 Oct.

18.

Heart involvement in cystic fibrosis: A specific cystic fibrosis-related myocardial changes?

Labombarda F, Saloux E, Brouard J, Bergot E, Milliez P.

Respir Med. 2016 Sep;118:31-38. doi: 10.1016/j.rmed.2016.07.011. Epub 2016 Jul 15. Review.

PMID:
27578468
19.

Co-recruitment analysis of the CBL and CBLB signalosomes in primary T cells identifies CD5 as a key regulator of TCR-induced ubiquitylation.

Voisinne G, García-Blesa A, Chaoui K, Fiore F, Bergot E, Girard L, Malissen M, Burlet-Schiltz O, Gonzalez de Peredo A, Malissen B, Roncagalli R.

Mol Syst Biol. 2016 Jul 29;12(7):876. doi: 10.15252/msb.20166837.

20.

Neurological involvement in hereditary hemorrhagic telangiectasia.

Labeyrie PE, Courthéoux P, Babin E, Bergot E, Touzé E, Pelage JP.

J Neuroradiol. 2016 Jul;43(4):236-45. doi: 10.1016/j.neurad.2016.02.005. Epub 2016 Apr 5. Review.

21.

Initial dual oral combination therapy in pulmonary arterial hypertension.

Sitbon O, Sattler C, Bertoletti L, Savale L, Cottin V, Jaïs X, De Groote P, Chaouat A, Chabannes C, Bergot E, Bouvaist H, Dauphin C, Bourdin A, Bauer F, Montani D, Humbert M, Simonneau G.

Eur Respir J. 2016 Jun;47(6):1727-36. doi: 10.1183/13993003.02043-2015. Epub 2016 Mar 17.

22.

Pulmonary complications of type 1 neurofibromatosis.

Reviron-Rabec L, Girerd B, Seferian A, Campbell K, Brosseau S, Bergot E, Humbert M, Zalcman G, Montani D.

Rev Mal Respir. 2016 Jun;33(6):460-73. doi: 10.1016/j.rmr.2014.09.010. Epub 2016 Feb 8. Review.

PMID:
26868668
23.

A prospective study of the 6 min walk test as a surrogate marker for haemodynamics in two independent cohorts of treatment-naïve systemic sclerosis-associated pulmonary arterial hypertension.

Sanges S, Launay D, Rhee RL, Sitbon O, Hachulla É, Mouthon L, Guillevin L, Rottat L, Montani D, De Groote P, Cottin V, Magro P, Prévot G, Bauer F, Bergot E, Chabanne C, Reynaud-Gaubert M, Leroy S, Canuet M, Sanchez O, Gut-Gobert C, Dauphin C, Pison C, Boissin C, Habib G, Clerson P, Conesa F, Cordier JF, Kawut SM, Simonneau G, Humbert M.

Ann Rheum Dis. 2016 Aug;75(8):1457-65. doi: 10.1136/annrheumdis-2015-207336. Epub 2015 Aug 31.

PMID:
26324844
24.

Antecubital vs Femoral Venous Access for Right Heart Catheterization: Benefits of a Flashback.

Roule V, Ailem S, Legallois D, Dahdouh Z, Lognoné T, Bergot E, Grollier G, Milliez P, Sabatier R, Beygui F.

Can J Cardiol. 2015 Dec;31(12):1497.e1-6. doi: 10.1016/j.cjca.2015.04.026. Epub 2015 Apr 30.

PMID:
26277087
25.

Tricuspid systolic peak velocity is a prognostic factor in patients with cystic fibrosis.

Labombarda F, Barigou A, Legallois D, Campbell K, Bergot E, Milliez P, Saloux E.

Int J Cardiol. 2015 Nov 15;199:435-6. doi: 10.1016/j.ijcard.2015.07.088. Epub 2015 Jul 30. No abstract available.

PMID:
26263010
26.

[Tuberculosis in 2015: From diagnosis to the detection of multiresistant cases].

Hervé C, Bergot E, Veziris N, Blanc FX.

Rev Mal Respir. 2015 Oct;32(8):784-90. doi: 10.1016/j.rmr.2015.06.008. Epub 2015 Jul 10. Review. French.

PMID:
26169235
27.

Budesonide/Formoterol for bronchiolitis obliterans after hematopoietic stem cell transplantation.

Bergeron A, Chevret S, Chagnon K, Godet C, Bergot E, Peffault de Latour R, Dominique S, de Revel T, Juvin K, Maillard N, Reman O, Contentin N, Robin M, Buzyn A, Socié G, Tazi A.

Am J Respir Crit Care Med. 2015 Jun 1;191(11):1242-9. doi: 10.1164/rccm.201410-1818OC.

PMID:
25835160
28.

[Dasatinib-related pneumonia? An example of pharmacovigilance survey].

Audemard A, de la Gastine B, Chantepie S, Verger H, Gac AC, Bergot E, Reman O.

Rev Mal Respir. 2015 Jan;32(1):84-6. doi: 10.1016/j.rmr.2014.08.002. Epub 2014 Sep 26. French. No abstract available.

PMID:
25618211
29.

Severe hematologic complications after lung transplantation in patients with telomerase complex mutations.

Borie R, Kannengiesser C, Hirschi S, Le Pavec J, Mal H, Bergot E, Jouneau S, Naccache JM, Revy P, Boutboul D, Peffault de la Tour R, Wemeau-Stervinou L, Philit F, Cordier JF, Thabut G, Crestani B, Cottin V; Groupe d’Etudes et de Recherche sur les Maladies “Orphelines” Pulmonaires (GERM“O”P).

J Heart Lung Transplant. 2015 Apr;34(4):538-46. doi: 10.1016/j.healun.2014.11.010. Epub 2014 Nov 13.

30.

Retrospective observational study of diagnostic accuracy of the Xpert® MTB/RIF assay on fiberoptic bronchoscopy sampling for early diagnosis of smear-negative or sputum-scarce patients with suspected tuberculosis.

Le Palud P, Cattoir V, Malbruny B, Magnier R, Campbell K, Oulkhouir Y, Zalcman G, Bergot E.

BMC Pulm Med. 2014 Aug 12;14:137. doi: 10.1186/1471-2466-14-137.

31.

Upfront triple combination therapy in pulmonary arterial hypertension: a pilot study.

Sitbon O, Jaïs X, Savale L, Cottin V, Bergot E, Macari EA, Bouvaist H, Dauphin C, Picard F, Bulifon S, Montani D, Humbert M, Simonneau G.

Eur Respir J. 2014 Jun;43(6):1691-7. doi: 10.1183/09031936.00116313. Epub 2014 Mar 13.

32.

Current epoprostenol use in patients with severe idiopathic, heritable or anorexigen-associated pulmonary arterial hypertension: data from the French pulmonary hypertension registry.

Bergot E, Sitbon O, Cottin V, Prévot G, Canuet M, Bourdin A, de Groote P, Rottat L, Gressin V, Jaïs X, Humbert M, Simonneau G.

Int J Cardiol. 2014 Apr 1;172(3):561-7. doi: 10.1016/j.ijcard.2013.12.313. Epub 2014 Jan 22.

PMID:
24529947
33.

EPITOME-2: An open-label study assessing the transition to a new formulation of intravenous epoprostenol in patients with pulmonary arterial hypertension.

Sitbon O, Delcroix M, Bergot E, Boonstra AB, Granton J, Langleben D, Subías PE, Galiè N, Pfister T, Lemarié JC, Simonneau G.

Am Heart J. 2014 Feb;167(2):210-7. doi: 10.1016/j.ahj.2013.08.007. Epub 2013 Oct 3.

34.

Predictive biomarkers in patients with resected non-small cell lung cancer treated with perioperative chemotherapy.

Bergot E, Levallet G, Campbell K, Dubois F, Lechapt E, Zalcman G.

Eur Respir Rev. 2013 Dec;22(130):565-76. doi: 10.1183/09059180.00007113. Review.

35.

[Malignant pleural mesothelioma: 2013 state of the art].

Campbell K, Brosseau S, Reviron-Rabec L, Bergot E, Lechapt E, Levallet G, Zalcman G.

Bull Cancer. 2013 Dec;100(12):1283-93. doi: 10.1684/bdc.2013.1857. Review. French.

PMID:
24225007
36.

[Interest of collapse therapy in pulmonary extensively drug-resistant tuberculosis].

Haustraete E, Campbell K, Magnier R, Zalcman G, Bergot É.

Rev Pneumol Clin. 2014 Aug;70(4):240-4. doi: 10.1016/j.pneumo.2013.08.007. Epub 2013 Nov 5. French.

PMID:
24210158
37.

Tyrosine kinase inhibitors in pulmonary arterial hypertension: a double-edge sword?

Godinas L, Guignabert C, Seferian A, Perros F, Bergot E, Sibille Y, Humbert M, Montani D.

Semin Respir Crit Care Med. 2013 Oct;34(5):714-24. doi: 10.1055/s-0033-1356494. Epub 2013 Sep 13. Review.

PMID:
24037637
38.

In vivo probe-based confocal laser endomicroscopy in amiodarone-related pneumonia.

Salaün M, Roussel F, Bourg-Heckly G, Vever-Bizet C, Dominique S, Genevois A, Jounieaux V, Zalcman G, Bergot E, Vergnon JM, Thiberville L.

Eur Respir J. 2013 Dec;42(6):1646-58. doi: 10.1183/09031936.00191911. Epub 2012 Sep 27.

39.

Observational study of QuantiFERON®-TB gold in-tube assay in tuberculosis contacts in a low incidence area.

Bergot E, Haustraete E, Malbruny B, Magnier R, Salaün MA, Zalcman G.

PLoS One. 2012;7(8):e43520. doi: 10.1371/journal.pone.0043520. Epub 2012 Aug 24.

40.

Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trial.

Cadranel J, Philippe B, Hennequin C, Bergeron A, Bergot E, Bourdin A, Cottin V, Jeanfaivre T, Godet C, Pineau M, Germaud P.

Eur J Clin Microbiol Infect Dis. 2012 Nov;31(11):3231-9. doi: 10.1007/s10096-012-1690-y. Epub 2012 Jul 11.

41.

Pulmonary hypertension associated with benfluorex exposure.

Savale L, Chaumais MC, Cottin V, Bergot E, Frachon I, Prevot G, Pison C, Dromer C, Poubeau P, Lamblin N, Habib G, Reynaud-Gaubert M, Bourdin A, Sanchez O, Tubert-Bitter P, Jaïs X, Montani D, Sitbon O, Simonneau G, Humbert M.

Eur Respir J. 2012 Nov;40(5):1164-72. doi: 10.1183/09031936.00188611. Epub 2012 Apr 20.

42.

Pulmonary arterial hypertension in patients treated by dasatinib.

Montani D, Bergot E, Günther S, Savale L, Bergeron A, Bourdin A, Bouvaist H, Canuet M, Pison C, Macro M, Poubeau P, Girerd B, Natali D, Guignabert C, Perros F, O'Callaghan DS, Jaïs X, Tubert-Bitter P, Zalcman G, Sitbon O, Simonneau G, Humbert M.

Circulation. 2012 May 1;125(17):2128-37. doi: 10.1161/CIRCULATIONAHA.111.079921. Epub 2012 Mar 26.

43.

An apoptosis methylation prognostic signature for early lung cancer in the IFCT-0002 trial.

de Fraipont F, Levallet G, Creveuil C, Bergot E, Beau-Faller M, Mounawar M, Richard N, Antoine M, Rouquette I, Favrot MC, Debieuvre D, Braun D, Westeel V, Quoix E, Brambilla E, Hainaut P, Moro-Sibilot D, Morin F, Milleron B, Zalcman G; Intergroupe Francophone de Cancérologie Thoracique.

Clin Cancer Res. 2012 May 15;18(10):2976-86. doi: 10.1158/1078-0432.CCR-11-2797. Epub 2012 Mar 20.

44.

High TUBB3 expression, an independent prognostic marker in patients with early non-small cell lung cancer treated by preoperative chemotherapy, is regulated by K-Ras signaling pathway.

Levallet G, Bergot E, Antoine M, Creveuil C, Santos AO, Beau-Faller M, de Fraipont F, Brambilla E, Levallet J, Morin F, Westeel V, Wislez M, Quoix E, Debieuvre D, Dubois F, Rouquette I, Pujol JL, Moro-Sibilot D, Camonis J, Zalcman G; Intergroupe Francophone de Cancérologie Thoracique (IFCT).

Mol Cancer Ther. 2012 May;11(5):1203-13. doi: 10.1158/1535-7163.MCT-11-0899. Epub 2012 Mar 12.

45.

Octreotide treatment of idiopathic pulmonary fibrosis: a proof-of-concept study.

Crestani B, Chapron J, Wallaert B, Bergot E, Delaval P, Israel-Biet D, Lacronique J, Monnet I, Reynaud-Gaubert M, Tazi A, Lebtahi R, Debray MP, Brauner M, Dehoux M, Dornic Q, Aubier M, Mentré F, Duval X.

Eur Respir J. 2012 Mar;39(3):772-5. doi: 10.1183/09031936.00113011. No abstract available.

46.

A STEPP too far for FLEX?

Bergot E, Creveuil C, Zalcman G.

Lancet Oncol. 2012 Feb;13(2):e51; author reply e51. doi: 10.1016/S1470-2045(12)70056-6. No abstract available.

PMID:
22300858
47.

Plasma cell membrane localization of c-MET predicts longer survival in patients with malignant mesothelioma: a series of 157 cases from the MESOPATH Group.

Levallet G, Vaisse-Lesteven M, Le Stang N, Ilg AG, Brochard P, Astoul P, Pairon JC, Bergot E, Zalcman G, Galateau-Sallé F.

J Thorac Oncol. 2012 Mar;7(3):599-606. doi: 10.1097/JTO.0b013e3182417da5.

48.

[Alterations of mechanical and immune host defenses causing pneumonia: the case of recurrent pneumonia].

Bergot E.

Rev Prat. 2011 Oct;61(8):1068. French. No abstract available.

PMID:
22135969
49.

[Epidemiology and mechanisms of pneumonia in adults].

Bergot E.

Rev Prat. 2011 Oct;61(8):1064-7, 1069-70. French.

PMID:
22135968
50.

Myocardial strain assessment in cystic fibrosis.

Labombarda F, Pellissier A, Ellafi M, Creveuil C, Ribault V, Laurans M, Guillot M, Bergot E, Grollier G, Milliez P, Zalcman G, Saloux E.

J Am Soc Echocardiogr. 2011 Sep;24(9):1037-45. doi: 10.1016/j.echo.2011.06.004. Epub 2011 Jul 18.

PMID:
21764552

Supplemental Content

Loading ...
Support Center